Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy in Heart Transplantation: New Strategies and Preliminary Results in Endomyocardial Biopsies

Monitoring Intra-cellular Tacrolimus Concentrations in Solid Organ Transplantation: Use of Peripheral Blood Mononuclear Cells and Graft Biopsy Tissue

(2021) Benedetta C. Sallustio   Frontiers in Pharmacology

Development and validation of a combined enzymatic-digestion/mass spectrometry assay for Tacrolimus quantitation in cardiac biopsies

(2020) Mariadelfina Molinaro et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

The meaning of donor-specific antibodies after heart transplant

(2019) Markus J. Barten et al.   Current Opinion in Organ Transplantation

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy

(2019) Mercè Brunet et al.   THERAPEUTIC DRUG MONITORING

High tacrolimus trough level variability is associated with rejections after heart transplantation

(2018) Itai Gueta et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients

(2018) Stephan R. Seibert et al.   CLINICAL TRANSPLANTATION

Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation

(2017) Jean-Baptiste Woillard et al.   Frontiers in Pharmacology

The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report—2016; Focus Theme: Primary Diagnostic Indications for Transplant

(2016) Lars H. Lund et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation

(2015) M. A. Sikma et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials†

(2013) R. Bouamar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) Haplotypes Significantly Affect the Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients

(2013) Ken Ogasawara et al.   CLINICAL PHARMACOKINETICS

Sample size and power determination in joint modeling of longitudinal and survival data

(2011) Liddy M. Chen et al.   STATISTICS IN MEDICINE

The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients

(2010) Maria Rosa Costanzo et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference

(2009) Pierre Wallemacq et al.   THERAPEUTIC DRUG MONITORING